MyFinsight
Home
Blog
About
Net (gain) income
-$19,032K
(-2949.10%↓ Y/Y)
Income tax (benefit)
expense
-$106K
(-138.97%↓ Y/Y)
Commercial Supply
Agreement-United Therapeutics...
$29,599K
License
Agreement-United Therapeutics...
$4,923K
Amphastar-Co Promotion
Agreement
$500K
(gain) income before
income tax expense
-$19,138K
(-2135.96%↓ Y/Y)
License And Service
$35,022K
Royalty
$32,370K
Furoscix
$22,191K
Afrezza
$17,021K
VGo
$2,770K
Total other expense
-$18,788K
(-331.02%↓ Y/Y)
(gain) income from
operations
-$350K
(-106.61%↓ Y/Y)
Interest income, net
$1,022K
(-44.21%↓ Y/Y)
Total revenues
$109,374K
(42.92%↑ Y/Y)
Interest expense
$11,894K
(4073.33%↑ Y/Y)
Other expense
-$4,992K
interest expense on
financing liability
$2,414K
(-0.78%↓ Y/Y)
Total expenses
$109,724K
(54.05%↑ Y/Y)
Interest expense on
liability for sale of...
$510K
(-85.32%↓ Y/Y)
(loss) gain on foreign
currency transaction
$486K
(109.06%↑ Y/Y)
Selling, general and
administrative
$58,302K
(84.37%↑ Y/Y)
Research and development
$18,001K
(31.63%↑ Y/Y)
Cost of revenue
$15,131K
(-5.20%↓ Y/Y)
Cost of goods sold -
commercial, excluding...
$14,409K
(212.76%↑ Y/Y)
Amortization of acquired
intangible assets
$4,367K
Back
Back
Income Statement
MANNKIND CORP (MNKD)
MANNKIND CORP (MNKD)
source: myfinsight.com